Supriya Lifescience Experiences Revision in Stock Evaluation Amid Market Gains

Dec 18 2024 10:35 AM IST
share
Share Via
Supriya Lifescience has seen a notable adjustment in its stock evaluation following a significant increase in its share price. The company outperformed its sector and has been added to MarketsMojo's list, reflecting positive momentum amid broader market fluctuations. This marks a reversal after a period of decline. On December 18, 2024, Supriya Lifescience, a midcap player in the pharmaceuticals and drugs industry, experienced a significant stock increase of 5.29%. This performance allowed the company to outperform its sector by 4.4%. The stock's upward trend marks a reversal after six consecutive days of decline. During the trading session, Supriya Lifescience reached an intraday high of Rs 755, reflecting a gain of 5.45%. An analysis of moving averages indicates that the stock is currently above the 5-day, 50-day, 100-day, and 200-day moving averages, although it remains below the 20-day moving average. In terms of broader market performance, Supriya Lifescience's one-day gain of 5.75% stands in contrast to the Sensex, which recorded a decline of 0.22%. Over the past month, the company's stock has risen by 16.59%, significantly outperforming the Sensex's increase of 4.10%. The stock call for Supriya Lifescience is currently rated as 'Hold' by MarketsMojo.
**Supriya Lifescience Sees Notable Gains Amid Market Fluctuations**

On December 18, 2024, Supriya Lifescience, a midcap player in the pharmaceuticals and drugs industry, experienced a significant stock increase of 5.29%. This performance allowed the company to outperform its sector by 4.4%. The stock's upward trend marks a reversal after six consecutive days of decline.

During the trading session, Supriya Lifescience reached an intraday high of Rs 755, reflecting a gain of 5.45%. An analysis of moving averages indicates that the stock is currently above the 5-day, 50-day, 100-day, and 200-day moving averages, although it remains below the 20-day moving average.

In terms of broader market performance, Supriya Lifescience's one-day gain of 5.75% stands in contrast to the Sensex, which recorded a decline of 0.22%. Over the past month, the company's stock has risen by 16.59%, significantly outperforming the Sensex's increase of 4.10%.

In light of these developments, there has been an adjustment in evaluation for Supriya Lifescience, reflecting the stock's recent performance and market dynamics. Additionally, the stock has been added to MarketsMOJO's list, indicating a positive shift in its market perception.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News